Portfolio
Advancing Portfolio
Screening Program
- RFP Year2017
- Awarded Amount$99,986
- DiseaseTuberculosis
- InterventionDrug
- Development StageHit Identification
- Collaboration PartnersAstellas Pharma Inc., The Global Alliance for TB Drug Development